Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas

The human endogenous retrovirus K10 (HERV-K10) has been identified in the human genome by its homology to retroviruses of other vertebrates (M. Ono, T. Yasunaga, T. Miyata, and H. Ushikubo, J. Virol. 60:589-598, 1986). Using PCR amplification, DNA cloning, sequencing, and procaryotic expression, we were able to demonstrate that HERV-K10 encodes a 73-kDa protein which was processed by a HERV-K10-encoded protease to yield proteins p22/p26, p30, and p15/16. Analysis of the teratocarcinoma cell line Tera 1 or tumor tissues by immunoblotting demonstrated that the 80-kDa polyprotein of HERV-K10 gag and a processed protein of 39 kDa were expressed. In addition, a major protein of 39 kDa and additional species of 30, 22, 19, and 17 kDa could be detected in the supernatant of Tera 1 cells, suggesting that HERV-K10 Gag proteins are either secreted or processed to probably incomplete viral particles. In addition, the gag gene of HERV-K10 was expressed in the baculovirus system. Using this recombinant system to test antisera from patients with different diseases and healthy individuals, we were able to detect antibodies against the N-terminal part of HERV-K10 Gag in 2 to 4% of groups of tumor patients with titers ranging between 1:80 and 1:640, while approximately 0.1 to 0.5% of healthy individuals exhibited antibodies with lower titers. In contrast, patients with seminoma had antibody titers in the range of 1:2,560 at the time when the tumor was detected. Immunohistochemistry using specific rabbit sera or monoclonal antibodies against HERV-K10 Gag revealed that the Gag protein is expressed in the cytoplasm of the tumor cells. Furthermore, an 80-kDa protein corresponding to the HERV-K10 Gag polyprotein could be detected in tumor biopsies. For the first time, these data indicate that HERV-K10 Gag proteins are synthesized in seminoma cells and tumors exhibit relatively high antibody titers against Gag. So far, no information on which role HERV-K10 plays in the development of this tumor exists.

[1]  R. Kurth,et al.  Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. , 1993, Virology.

[2]  R. Kurth,et al.  Identification of human endogenous retroviruses with complex mRNA expression and particle formation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  F. Grässer,et al.  Human endogenous retroviral element K10 (HERV-K10) encodes a full-length gag homologous 73-kDa protein and a functional protease. , 1993, AIDS research and human retroviruses.

[4]  E. Coutavas,et al.  Evolutionary implications of primate endogenous retroviruses. , 1991, Virology.

[5]  G. Lenoir,et al.  Identification of Epstein-Barr virus terminal protein 1 (TP1) in extracts of four lymphoid cell lines, expression in insect cells, and detection of antibodies in human sera , 1990, Journal of virology.

[6]  R. Mariani-Costantini,et al.  Ancestry of a human endogenous retrovirus family , 1989, Journal of virology.

[7]  H. Rochefort,et al.  Expression of human sequences related to those of mouse mammary tumor virus , 1988, Journal of virology.

[8]  J. Keene,et al.  A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30 gag antigen , 1987, Cell.

[9]  R. Ohlsson,et al.  Tissue-specific expression of human provirus ERV3 mRNA in human placenta: two of the three ERV3 mRNAs contain human cellular sequences , 1987, Journal of virology.

[10]  M. Ono,et al.  Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D , 1987, Journal of virology.

[11]  T. Miyata,et al.  Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome , 1986, Journal of virology.

[12]  F. Studier,et al.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. , 1986, Journal of molecular biology.

[13]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Radu,et al.  Establishment and characterization of a cell line of human breast carcinoma origin. , 1979, European journal of cancer.

[15]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[16]  A. Myers,et al.  High-expression vectors with multiple cloning sites for construction of trpE fusion genes: pATH vectors. , 1991, Methods in enzymology.

[17]  M. Cohen,et al.  Human endogenous proviruses. , 1989, Current topics in microbiology and immunology.

[18]  F. Sánchez‐Madrid,et al.  Monoclonal antibodies specific for rat IgG1, IgG2a, and IgG2b subclasses, and kappa chain monotypic and allotypic determinants: reagents for use with rat monoclonal antibodies. , 1982, Hybridoma.

[19]  J. Fogh,et al.  New Human Tumor Cell Lines , 1975 .

[20]  G. Miller,et al.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.